Canada markets closed

PFE Feb 2023 30.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
18.900.00 (0.00%)
At close: 09:45AM EST
Full screen
Previous Close18.90
Open18.90
Bid21.05
Ask21.20
Strike30.00
Expire Date2023-02-17
Day's Range18.90 - 18.90
Contract RangeN/A
Volume4
Open Interest28
  • Motley Fool

    Why Shares of Prometheus Biosciences Slumped This Week

    Shares of Prometheus Biosciences (NASDAQ: RXDX) were down more than 12% this week as of Friday morning, according to data from S&P Global Intelligence. The clinical-stage biotech company specializes in immunotherapies with a focus on inflammatory bowel disease (IBD). Prometheus' lead therapy in its pipeline is IBD drug PRA023.

  • Zacks

    Roivant (ROIV), Pfizer Form Vant for Inflammatory Disease Drug

    Roivant Sciences (ROIV), Pfizer's (PFE) new Vant company will take care of funding the global development of RVT-3101 in inflammatory and fibrotic diseases.

  • Zacks

    Valneva (VALN) Up on 6-Month Lyme Disease Jab Persistence Data

    Persistence data from a mid-stage study showed that Valneva's (VALN) Lyme disease vaccine elicited antibody levels which remained above baseline six months after completing dose administration in children and adults.